BOLT
Bolt Biotherapeutics, Inc. · Healthcare
Director Edgar Engleman sold $129K of Bolt Biotherapeutics, Inc.
Sold$128,993
$0.87Price
148,884Shares
−7%Stake
What BOLT did after the filing
Prices for BOLT after this filing aren't in yet.
Traded Wed, Nov 29. Filed Fri, Dec 1, 7:31 AM ET, before the open. Not investment advice.